Standing Order
All companies

Biotech

Absci Corporation

ABSINASDAQpure-play
Market cap$1.1B
Conviction2/ 5
HQVancouver, Washington, USA

For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.

Price · 180d

$6.75

+122.0%

Thesis

Absci pairs generative AI antibody design with integrated wet-lab validation to create and optimize biologics. The platform aims to compress discovery timelines through both internal programs and pharma partnerships.

Catalysts

  • Lead candidate progression toward the clinic
  • New AI antibody-design partnerships
  • Validation of generative design against conventional discovery

Not financial advice — research and opinion only. Disclosures